Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Measure of Pharmacokinetic Parameters and Adherence With MEMS in Naive HIV Infected Patients Treated With Reyataz Once Daily Combined With Norvir and Truvada (ANRS134COPHAR3)

This study has been completed.
Bristol-Myers Squibb
Gilead Sciences
Information provided by (Responsible Party):
French National Agency for Research on AIDS and Viral Hepatitis Identifier:
First received: September 10, 2007
Last updated: December 21, 2011
Last verified: December 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2008
  Primary Completion Date: November 2008 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):